Geneva
Switzerland
4
2009-02-12
4
2011-08-30
These are the the leading inventors for applications assigned to Stragen Pharma S.A.:
Stragen Pharma S.A. based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2-tetrahydropyran carboxylic acid
#2 | 2007-10-23 ✅ Patent 7,285,546 granted on 2007-10-23Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
#3 | 2006-01-17 ✅ Patent 6,987,103 granted on 2006-01-17Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents
#4 | 2005-04-28 ✅ Patent 7,169,774 granted on 2007-01-30Cephalotaxane derivatives and their processes of preparation and purification
393305 ⎘